All News
STAT+: AstraZeneca, Daiichi Sankyo change strategy on closely watched cancer drug
A closely watched cancer drug from AstraZeneca and Daiichi Sankyo could take longer to reach the market.
Read MoreKim Leadbeater outlines safeguards in proposed assisted dying bill – video
A bill to legalise assisted dying in England and Wales will set out hardline safeguards, including lengthy prison sentences for coercion and powers for judges to cross-examine patients.
Read MoreOlder Americans Living Alone Often Rely on Neighbors or Others Willing To Help
Diverse networks of friends, former co-workers, neighbors, and extended family are often essential sources of support for older adults living alone. Often it is the elderly caring for the elderly.
Read MoreIndia’s Rs 500 crore MedTech scheme to boost domestic manufacturing and export of medical devices
New government scheme aims to transform India’s medical devices industry, promoting self-reliance and export growth through local manufacturing support The post India’s Rs 500 crore MedTech schem
Read MoreGlobal Coalition of TB Advocates launches youth-driven movement to strengthen tuberculosis advocacy
GCTA-Y empowers young advocates across multiple countries to lead in the fight against TB through training and collaboration with global health agencies The post Global Coalition of TB Advocates laun
Read MoreManipal Hospitals conducts workshop on Advanced Complex PCI Techniques, led by French cardiologist
Cardiologists gather at Manipal Hospitals, Mukundapur for live demonstrations on latest PCI advancements to address rising cardiac issues in India The post Manipal Hospitals conducts workshop on Adva
Read MoreNHS England hopes to save thousands of lives with pill that helps smokers quit
Experts say once-a-day varenicline tablet reduces nicotine cravings and side-effects from cutting out tobaccoHundreds of thousands of smokers will be given a pill that increases people’s chances of
Read MoreSTAT+: The end of 23andMe’s drug discovery dream
23andMe, the genetics startup that has repeatedly captured the public imagination and then faced nearly fatal business challenges, announced it would lay off 40% of its workforce.
Read MoreAlzheimer's Data Withdrawn
(MedPage Today) -- A preprint research letter linking the Alzheimer's drug lecanemab (Leqembi) with excess deaths was withdrawn last week.
Read MoreEarly Intratracheal Budesonide Didn't Improve Outcomes for Preterm Infants
(MedPage Today) -- In extremely preterm infants receiving surfactant, early intratracheal budesonide had little to no effect on survival free of bronchopulmonary dysplasia (BPD), a randomized clinica
Read More